Access Solutions Behavioral Health

Access Solutions Behavioral Health offers Spravato in Tulsa, Oklahoma for adults with treatment-resistant depression and for those with major depressive disorder experiencing acute suicidal ideation. The FDA-approved esketamine nasal spray is administered in a certified clinical setting alongside an oral antidepressant.

The Spravato clinic operates inside the practice's existing behavioral health office, so the same psychiatric team managing medications and progress also oversees the Spravato sessions. Treatment follows a structured schedule, beginning with twice-weekly induction and tapering based on response.

Patients self-administer the nasal spray under supervision and remain monitored for at least two hours afterward, with a ride home arranged for treatment days. The administrative team handles prior authorization and coordinates coverage to support access to care.